DrugPatentWatch Database Preview
NUVESSA Drug Profile
When do Nuvessa patents expire, and what generic alternatives are available?
Nuvessa is a drug marketed by Chemo Research Sl and is included in one NDA. There are five patents protecting this drug.
This drug has fourteen patent family members in nine countries.
The generic ingredient in NUVESSA is metronidazole. There are eighteen drug master file entries for this compound. Ninety suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
Summary for NUVESSA
| International Patents: | 14 |
| US Patents: | 5 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 125 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | NUVESSA at DailyMed |
Pharmacology for NUVESSA
| Drug Class | Nitroimidazole Antimicrobial |
Medical Subject Heading (MeSH) Categories for NUVESSA
US Patents and Regulatory Information for NUVESSA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Chemo Research Sl | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for NUVESSA
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2009097143 | ➤ Sign Up |
| Australia | 2016200825 | ➤ Sign Up |
| China | 103763925 | ➤ Sign Up |
| Canada | 2840571 | ➤ Sign Up |
| Japan | 2014518272 | ➤ Sign Up |
| Argentina | 070406 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for NUVESSA
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C0021 | Belgium | ➤ Sign Up | PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
